Search Results 71-80 of 16810 for Selective estrogen receptor modulator

1. Conjugated estrogens (vaginal route) - Mayo Clinic

   Conjugated estrogens vaginal cream is used to treat changes in and around the vagina (such as vaginal dryness, itching, and burning) caused by low estrogen ...

2. Project 1: The Influence of Variants in ER-Positive Breast Cancer Predisposition Genes on Breast Cancer Risk and Response to Therapy - Mayo Clinic Research

   Of these, pathogenic variants in BRCA2, PALB2, ATM and CHEK2 are associated mainly with estrogen receptor (ER) positive breast cancer, which is also called ...

3. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

   ... Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer. Print details. Share; Facebook · Twitter. Overview ...

4. A Study Of Imlunestrant Versus Standard Endocrine Therapy In Participants With Early Breast Cancer - Mayo Clinic

   ... hormone therapy in participants with early breast cancer that is estrogen receptor positive (ER+) and human epidermal receptor 2 negative (HER2-).

5. Exemestane (oral route) - Side effects & dosage - Mayo Clinic

   It is usually used in women who have already received a cancer medication called tamoxifen. Many breast cancer tumors grow in response to estrogen. Exemestane ...

6. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

   ... receptor positive, estrogen receptor-positive, human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous endocrine ...

7. Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer - Mayo Clinic

   Ribociclib may stop the growth of tumor cells by blocking some enzymes needed for cell growth. Cancer cells that are estrogen receptor positive may need ...

8. Mayo Clinic researchers investigate novel radiopharmaceutical therapy for breast cancer

   The clinical trial investigates actinium-225 DOTATATE, a highly potent alpha-emitting radiopharmaceutical therapy, for the treatment of estrogen receptor- ...

9. A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence - Mayo Clinic

   ... Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence. Participation ...

10. HER2-Positive Breast Cancer Clinical Trials - Mayo Clinic Research

    ... Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer Rochester, MN ... estrogen receptor (ER)-positive breast cancer undergoing surgery. TTM is ...